Word

Status

Dead

Status Code

606

Status Date

Monday, October 2, 2023

Serial Number

88744866

Mark Type

2000

Filing Date

Thursday, January 2, 2020

Published for Opposition

Tuesday, July 7, 2020

Abandoned Date

Monday, October 2, 2023

Trademark Owner History

Ring Therapeutics, Inc. - Owner At Publication

Classifications

5 encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy

The mark consists of a stylized semi-circle.
Color is not claimed as a feature of the mark.

Trademark Events

Oct 2, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Oct 2, 2023

Abandonment - No Use Statement Filed

Mar 10, 2023

Notice Of Approval Of Extension Request E-Mailed

Mar 9, 2023

Sou Extension 5 Granted

Feb 24, 2023

Sou Extension 5 Filed

Mar 9, 2023

Case Assigned To Intent To Use Paralegal

Feb 24, 2023

Sou Teas Extension Received

Sep 1, 2022

Notice Of Approval Of Extension Request E-Mailed

Aug 30, 2022

Sou Extension 4 Granted

Aug 30, 2022

Sou Extension 4 Filed

Aug 30, 2022

Sou Teas Extension Received

Mar 2, 2022

Notice Of Approval Of Extension Request E-Mailed

Feb 28, 2022

Sou Extension 3 Granted

Feb 28, 2022

Sou Extension 3 Filed

Feb 28, 2022

Sou Teas Extension Received

Aug 27, 2021

Notice Of Approval Of Extension Request E-Mailed

Aug 25, 2021

Sou Extension 2 Granted

Aug 25, 2021

Sou Extension 2 Filed

Aug 25, 2021

Sou Teas Extension Received

Mar 3, 2021

Notice Of Approval Of Extension Request E-Mailed

Mar 1, 2021

Sou Extension 1 Granted

Mar 1, 2021

Sou Extension 1 Filed

Mar 1, 2021

Sou Teas Extension Received

Sep 1, 2020

Noa E-Mailed - Sou Required From Applicant

Jul 7, 2020

Official Gazette Publication Confirmation E-Mailed

Jul 7, 2020

Published For Opposition

Jun 17, 2020

Notification Of Notice Of Publication E-Mailed

May 29, 2020

Approved For Pub - Principal Register

May 27, 2020

Teas/Email Correspondence Entered

May 26, 2020

Correspondence Received In Law Office

May 26, 2020

Teas Response To Office Action Received

Mar 24, 2020

Notification Of Non-Final Action E-Mailed

Mar 24, 2020

Non-Final Action E-Mailed

Mar 24, 2020

Non-Final Action Written

Mar 24, 2020

Assigned To Examiner

Jan 11, 2020

Notice Of Design Search Code E-Mailed

Jan 10, 2020

New Application Office Supplied Data Entered